Related Experiment Video
Updated: Apr 22, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Investigation of phosphoproteome in RAGE signaling
Kedar B Batkulwar1, Sneha B Bansode, Gouri V Patil
1Proteomics Facility, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India.
Abstract:
The receptor for advanced glycation end products (RAGE) is one of the most important proteins implicated in diabetes, cardiovascular diseases, neurodegenerative diseases, and cancer. It is a pattern recognition receptor by virtue of its ability to interact with multiple ligands, RAGE activates several signal transduction pathways through involvement of various kinases that phosphorylate their respective substrates. Only few substrates have been known to be phosphorylated in response to activation by RAGE (e.g., nuclear factor kappa B); however, it is possible that these kinases can phosphorylate multiple substrates depending upon their expression and localization, leading to altered cellular responses in different cell types and conditions. One such example is, glycogen synthase kinase 3 beta which is known to phosphorylate glycogen synthase, acts downstream to RAGE, and hyperphosphorylates microtubule-associated protein tau causing neuronal damage. Thus, it is important to understand the role of various RAGE-activated kinases and their substrates. Therefore, we have reviewed here the details of RAGE-activated kinases in response to different ligands and their respective phosphoproteome. Furthermore, we discuss the analysis of the data mined for known substrates of these kinases from the PhosphoSitePlus (http://www.phosphosite.org) database, and the role of some of the important substrates involved in cancer, diabetes, cardiovascular diseases, and neurodegenerative diseases. In summary, this review provides information on RAGE-activated kinases and their phosphoproteome, which will be helpful in understanding the possible role of RAGE and its ligands in progression of diseases.
Insights
The receptor for advanced glycation end products (RAGE) activates kinases that phosphorylate substrates, impacting diseases like cancer and diabetes. Understanding these RAGE-activated kinases and their phosphoproteome is crucial for disease research.
Area of Science:
- Molecular Biology
- Cell Signaling
- Disease Mechanisms
Background:
- The receptor for advanced glycation end products (RAGE) is a key protein in diabetes, cardiovascular diseases, neurodegenerative diseases, and cancer.
- RAGE acts as a pattern recognition receptor, interacting with multiple ligands and activating signal transduction pathways via kinases.
Purpose of the Study:
- To review RAGE-activated kinases and their phosphoproteome in response to various ligands.
- To analyze known kinase substrates from the PhosphoSitePlus database.
- To discuss the role of these substrates in major diseases.
Main Methods:
- Literature review of RAGE-activated kinases and their substrates.
- Data mining from the PhosphoSitePlus database for kinase-substrate interactions.
- Analysis of substrate roles in cancer, diabetes, cardiovascular, and neurodegenerative diseases.
Main Results:
- Identified multiple RAGE-activated kinases and their associated phosphoproteome.
- Cataloged known substrates for these kinases, highlighting their involvement in disease pathways.
- Provided examples like glycogen synthase kinase 3 beta (GSK3B) and its role in neuronal damage.
Conclusions:
- Understanding RAGE-activated kinases and their phosphoproteome is essential for elucidating RAGE's role in disease progression.
- This knowledge can guide the development of targeted therapies for RAGE-mediated diseases.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Amplifying Signals via Enzymatic Cascade
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway

